

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.32242826 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.19012083 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.17727542 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.13497920 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.56549078 |
| 6 | vocalization behavior (GO:0071625) | 5.41855945 |
| 7 | regulation of synapse structural plasticity (GO:0051823) | 5.37547016 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.31787655 |
| 9 | L-amino acid import (GO:0043092) | 5.18873056 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.17056388 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.14551261 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.10312511 |
| 13 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.04422687 |
| 14 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.99831426 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.92798851 |
| 16 | cerebellar granule cell differentiation (GO:0021707) | 4.80308277 |
| 17 | glutamate secretion (GO:0014047) | 4.77211448 |
| 18 | amino acid import (GO:0043090) | 4.67399857 |
| 19 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.54118001 |
| 20 | dendritic spine morphogenesis (GO:0060997) | 4.53303388 |
| 21 | exploration behavior (GO:0035640) | 4.49799639 |
| 22 | neuronal action potential propagation (GO:0019227) | 4.49360190 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.47913502 |
| 24 | protein localization to synapse (GO:0035418) | 4.44233179 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.42495016 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 4.42154096 |
| 27 | neurotransmitter secretion (GO:0007269) | 4.40090589 |
| 28 | prepulse inhibition (GO:0060134) | 4.39739545 |
| 29 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.39389467 |
| 30 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.24601493 |
| 31 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.22688515 |
| 32 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.21975365 |
| 33 | long-term memory (GO:0007616) | 4.16970585 |
| 34 | potassium ion homeostasis (GO:0055075) | 4.14099956 |
| 35 | positive regulation of membrane potential (GO:0045838) | 4.12971339 |
| 36 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.12359813 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 4.12152388 |
| 38 | layer formation in cerebral cortex (GO:0021819) | 4.11842331 |
| 39 | auditory behavior (GO:0031223) | 4.11595054 |
| 40 | axon ensheathment in central nervous system (GO:0032291) | 4.04501369 |
| 41 | central nervous system myelination (GO:0022010) | 4.04501369 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.04056953 |
| 43 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.03909138 |
| 44 | neuromuscular process controlling balance (GO:0050885) | 4.03434244 |
| 45 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.01217744 |
| 46 | neuron-neuron synaptic transmission (GO:0007270) | 4.00540416 |
| 47 | potassium ion import (GO:0010107) | 3.97664373 |
| 48 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.92224495 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.91544682 |
| 50 | postsynaptic membrane organization (GO:0001941) | 3.90074379 |
| 51 | synaptic transmission, dopaminergic (GO:0001963) | 3.87152106 |
| 52 | positive regulation of neurotransmitter transport (GO:0051590) | 3.86343340 |
| 53 | regulation of synapse maturation (GO:0090128) | 3.86232139 |
| 54 | regulation of synaptic plasticity (GO:0048167) | 3.85443418 |
| 55 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.84938472 |
| 56 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.84552140 |
| 57 | glutamate receptor signaling pathway (GO:0007215) | 3.80385302 |
| 58 | gamma-aminobutyric acid transport (GO:0015812) | 3.75698610 |
| 59 | regulation of postsynaptic membrane potential (GO:0060078) | 3.75255908 |
| 60 | activation of protein kinase A activity (GO:0034199) | 3.74710193 |
| 61 | response to auditory stimulus (GO:0010996) | 3.71306443 |
| 62 | adenosine receptor signaling pathway (GO:0001973) | 3.71272970 |
| 63 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.66978305 |
| 64 | striatum development (GO:0021756) | 3.64787915 |
| 65 | cell communication by electrical coupling (GO:0010644) | 3.63806322 |
| 66 | neuron cell-cell adhesion (GO:0007158) | 3.59390100 |
| 67 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.58465009 |
| 68 | transmission of nerve impulse (GO:0019226) | 3.58236772 |
| 69 | neuronal ion channel clustering (GO:0045161) | 3.55678697 |
| 70 | cellular potassium ion homeostasis (GO:0030007) | 3.53600517 |
| 71 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.51073153 |
| 72 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.50566415 |
| 73 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.50226859 |
| 74 | cellular sodium ion homeostasis (GO:0006883) | 3.47534474 |
| 75 | long-term synaptic potentiation (GO:0060291) | 3.47359349 |
| 76 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.44283486 |
| 77 | dendritic spine organization (GO:0097061) | 3.44127068 |
| 78 | neurotransmitter transport (GO:0006836) | 3.43490207 |
| 79 | glycine transport (GO:0015816) | 3.43170309 |
| 80 | response to amphetamine (GO:0001975) | 3.42359380 |
| 81 | regulation of female receptivity (GO:0045924) | 3.42334769 |
| 82 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.41786023 |
| 83 | acidic amino acid transport (GO:0015800) | 3.41104882 |
| 84 | behavioral response to cocaine (GO:0048148) | 3.37641979 |
| 85 | regulation of neurotransmitter secretion (GO:0046928) | 3.37203886 |
| 86 | dopamine receptor signaling pathway (GO:0007212) | 3.36088895 |
| 87 | regulation of dendritic spine development (GO:0060998) | 3.34727595 |
| 88 | proline transport (GO:0015824) | 3.34044497 |
| 89 | sodium ion export (GO:0071436) | 3.31620874 |
| 90 | vesicle docking involved in exocytosis (GO:0006904) | 3.31610117 |
| 91 | regulation of neurotransmitter levels (GO:0001505) | 3.29812562 |
| 92 | positive regulation of synapse maturation (GO:0090129) | 3.29643908 |
| 93 | regulation of neurotransmitter transport (GO:0051588) | 3.28613850 |
| 94 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.26503563 |
| 95 | membrane hyperpolarization (GO:0060081) | 3.26255276 |
| 96 | neurotransmitter uptake (GO:0001504) | 3.25954769 |
| 97 | neuromuscular process controlling posture (GO:0050884) | 3.25180453 |
| 98 | neuromuscular synaptic transmission (GO:0007274) | 3.24181632 |
| 99 | regulation of vesicle fusion (GO:0031338) | 3.22974283 |
| 100 | regulation of glutamate secretion (GO:0014048) | 3.22180131 |
| 101 | membrane depolarization (GO:0051899) | 3.20747922 |
| 102 | synaptic vesicle transport (GO:0048489) | 3.20219348 |
| 103 | establishment of synaptic vesicle localization (GO:0097480) | 3.20219348 |
| 104 | positive regulation of dendritic spine development (GO:0060999) | 3.19949515 |
| 105 | synaptic transmission (GO:0007268) | 3.18945934 |
| 106 | regulation of exocytosis (GO:0017157) | 3.18428702 |
| 107 | positive regulation of synaptic transmission (GO:0050806) | 3.16531894 |
| 108 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.16379484 |
| 109 | learning (GO:0007612) | 3.16257441 |
| 110 | visual learning (GO:0008542) | 3.15977390 |
| 111 | positive regulation of dendrite development (GO:1900006) | 3.15864489 |
| 112 | regulation of ARF protein signal transduction (GO:0032012) | 3.15540640 |
| 113 | behavioral defense response (GO:0002209) | 3.14763794 |
| 114 | behavioral fear response (GO:0001662) | 3.14763794 |
| 115 | mechanosensory behavior (GO:0007638) | 3.11049553 |
| 116 | membrane depolarization during action potential (GO:0086010) | 3.10274688 |
| 117 | neuromuscular process (GO:0050905) | 3.10183125 |
| 118 | cell differentiation in hindbrain (GO:0021533) | 3.06249137 |
| 119 | synaptic vesicle endocytosis (GO:0048488) | 3.06099807 |
| 120 | dicarboxylic acid transport (GO:0006835) | 3.05662551 |
| 121 | signal release (GO:0023061) | 3.04782731 |
| 122 | female mating behavior (GO:0060180) | 3.04496076 |
| 123 | vesicle transport along microtubule (GO:0047496) | 3.04436771 |
| 124 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.03183593 |
| 125 | vesicle docking (GO:0048278) | 3.02552706 |
| 126 | regulation of synaptic transmission (GO:0050804) | 3.00910732 |
| 127 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.00400288 |
| 128 | visual behavior (GO:0007632) | 3.00151955 |
| 129 | chemosensory behavior (GO:0007635) | 3.00041221 |
| 130 | response to histamine (GO:0034776) | 2.98179154 |
| 131 | mating behavior (GO:0007617) | 2.97189482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.70838886 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.52381232 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.16941750 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10259144 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07961641 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.87885547 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.86090117 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.85940502 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.82638420 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.82638420 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.79051726 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.65313662 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.64549185 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.63698393 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63172940 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54000862 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.48720492 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.41282018 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.40528488 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.39895608 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.39229293 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.35865644 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.34586840 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.27946126 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.10032863 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.93204185 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.89661444 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81344089 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.80021790 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77324719 |
| 31 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.53128336 |
| 32 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.48036134 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47529420 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41691891 |
| 35 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.39904343 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.39841636 |
| 37 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38733021 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38064676 |
| 39 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37837352 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36695816 |
| 41 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31783741 |
| 42 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.31526312 |
| 43 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.31268971 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30934013 |
| 45 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28962882 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28242830 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25847716 |
| 48 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24708995 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23066788 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20241477 |
| 51 | * AR_19668381_ChIP-Seq_PC3_Human | 1.20107691 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.18822220 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18821544 |
| 54 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16694086 |
| 55 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.16626279 |
| 56 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16543075 |
| 57 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.16042777 |
| 58 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13705371 |
| 59 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13075927 |
| 60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12260562 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11169840 |
| 62 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10659305 |
| 63 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.10481642 |
| 64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09670287 |
| 65 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.09340814 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09295157 |
| 67 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08861308 |
| 68 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.08235109 |
| 69 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05258786 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04731985 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04645286 |
| 72 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03370859 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02445054 |
| 74 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02240844 |
| 75 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01057106 |
| 76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00825832 |
| 77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00580412 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00211873 |
| 79 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.99717961 |
| 80 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99310391 |
| 81 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98567074 |
| 82 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.97332756 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96610117 |
| 84 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96446702 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95939715 |
| 86 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95682595 |
| 87 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95249449 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95115077 |
| 89 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95019219 |
| 90 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94131244 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93802556 |
| 92 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93724892 |
| 93 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93682847 |
| 94 | * P68_20966046_ChIP-Seq_HELA_Human | 0.92669507 |
| 95 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91978037 |
| 96 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91922447 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91223019 |
| 98 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90531435 |
| 99 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90381155 |
| 100 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.90024062 |
| 101 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88645939 |
| 102 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88396017 |
| 103 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88057637 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86772934 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85688518 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84840469 |
| 107 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84781020 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84367894 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84225714 |
| 110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83584151 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83285182 |
| 112 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.83127591 |
| 113 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82694963 |
| 114 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82443783 |
| 115 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81958158 |
| 116 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81941949 |
| 117 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81741092 |
| 118 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80357527 |
| 119 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80322036 |
| 120 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80166264 |
| 121 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.79946653 |
| 122 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79691694 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.79627550 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79274909 |
| 125 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.79183973 |
| 126 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.78831294 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78581290 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.77623850 |
| 129 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77156347 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.77126324 |
| 131 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74300864 |
| 132 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.73982627 |
| 133 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.72906694 |
| 134 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.71036457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.21671161 |
| 2 | MP0002822_catalepsy | 5.84715873 |
| 3 | MP0003880_abnormal_central_pattern | 4.36877243 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.33378943 |
| 5 | MP0004270_analgesia | 3.75332600 |
| 6 | MP0009745_abnormal_behavioral_response | 3.65284261 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.53780203 |
| 8 | MP0002064_seizures | 3.18537931 |
| 9 | MP0009046_muscle_twitch | 2.89533693 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.83842668 |
| 11 | MP0001486_abnormal_startle_reflex | 2.68354864 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.67548674 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.63009229 |
| 14 | MP0002272_abnormal_nervous_system | 2.59922495 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.43245832 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.35603728 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.25179917 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.07251108 |
| 19 | MP0005646_abnormal_pituitary_gland | 1.98213512 |
| 20 | MP0008569_lethality_at_weaning | 1.95197591 |
| 21 | MP0001970_abnormal_pain_threshold | 1.88283225 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.85690456 |
| 23 | MP0002736_abnormal_nociception_after | 1.84925338 |
| 24 | MP0004811_abnormal_neuron_physiology | 1.82697263 |
| 25 | MP0001440_abnormal_grooming_behavior | 1.81182839 |
| 26 | MP0001529_abnormal_vocalization | 1.78700361 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.75023081 |
| 28 | MP0004924_abnormal_behavior | 1.75023081 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.70944036 |
| 30 | MP0002735_abnormal_chemical_nociception | 1.66892591 |
| 31 | MP0003123_paternal_imprinting | 1.65080874 |
| 32 | MP0003329_amyloid_beta_deposits | 1.64569447 |
| 33 | MP0003879_abnormal_hair_cell | 1.63353366 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.62938201 |
| 35 | MP0004858_abnormal_nervous_system | 1.62591731 |
| 36 | MP0002184_abnormal_innervation | 1.47952437 |
| 37 | MP0001984_abnormal_olfaction | 1.45677603 |
| 38 | MP0004885_abnormal_endolymph | 1.45280003 |
| 39 | MP0000955_abnormal_spinal_cord | 1.43563447 |
| 40 | MP0003633_abnormal_nervous_system | 1.42861700 |
| 41 | MP0003075_altered_response_to | 1.41157827 |
| 42 | MP0003283_abnormal_digestive_organ | 1.40750486 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.36624257 |
| 44 | MP0000778_abnormal_nervous_system | 1.29308506 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.28419012 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.28104362 |
| 47 | MP0003787_abnormal_imprinting | 1.19015749 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.15734276 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.15317658 |
| 50 | MP0008872_abnormal_physiological_respon | 1.15285501 |
| 51 | MP0001177_atelectasis | 1.15147274 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.14759393 |
| 53 | MP0001905_abnormal_dopamine_level | 1.14477967 |
| 54 | MP0003631_nervous_system_phenotype | 1.12627393 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.12539546 |
| 56 | MP0008874_decreased_physiological_sensi | 1.11668485 |
| 57 | MP0005409_darkened_coat_color | 1.08922929 |
| 58 | MP0001188_hyperpigmentation | 1.07277302 |
| 59 | MP0002069_abnormal_eating/drinking_beha | 1.00253944 |
| 60 | MP0001346_abnormal_lacrimal_gland | 0.99051245 |
| 61 | MP0002152_abnormal_brain_morphology | 0.98745377 |
| 62 | MP0005535_abnormal_body_temperature | 0.97546424 |
| 63 | MP0003690_abnormal_glial_cell | 0.95953129 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 0.92099491 |
| 65 | MP0004142_abnormal_muscle_tone | 0.91629711 |
| 66 | MP0004085_abnormal_heartbeat | 0.91203127 |
| 67 | MP0002090_abnormal_vision | 0.89354363 |
| 68 | MP0006276_abnormal_autonomic_nervous | 0.87248440 |
| 69 | MP0000569_abnormal_digit_pigmentation | 0.87169220 |
| 70 | MP0000920_abnormal_myelination | 0.84592551 |
| 71 | MP0002229_neurodegeneration | 0.83684186 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.83581475 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.83429080 |
| 74 | MP0010386_abnormal_urinary_bladder | 0.83269973 |
| 75 | MP0004043_abnormal_pH_regulation | 0.82336053 |
| 76 | MP0000751_myopathy | 0.79812000 |
| 77 | MP0004147_increased_porphyrin_level | 0.77112341 |
| 78 | MP0005394_taste/olfaction_phenotype | 0.76217482 |
| 79 | MP0005499_abnormal_olfactory_system | 0.76217482 |
| 80 | MP0003634_abnormal_glial_cell | 0.75234684 |
| 81 | MP0003122_maternal_imprinting | 0.72802885 |
| 82 | MP0000604_amyloidosis | 0.71380757 |
| 83 | MP0008877_abnormal_DNA_methylation | 0.70560911 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.70249285 |
| 85 | MP0004145_abnormal_muscle_electrophysio | 0.68078375 |
| 86 | MP0003632_abnormal_nervous_system | 0.67879355 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 0.67461717 |
| 88 | MP0004130_abnormal_muscle_cell | 0.66317213 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.65464354 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.63554373 |
| 91 | MP0003137_abnormal_impulse_conducting | 0.62951425 |
| 92 | MP0001664_abnormal_digestion | 0.62028374 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.58617985 |
| 94 | MP0004742_abnormal_vestibular_system | 0.58438965 |
| 95 | MP0000579_abnormal_nail_morphology | 0.57628625 |
| 96 | MP0004510_myositis | 0.56755554 |
| 97 | MP0001963_abnormal_hearing_physiology | 0.56725937 |
| 98 | MP0005166_decreased_susceptibility_to | 0.54378094 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.50699436 |
| 100 | MP0002752_abnormal_somatic_nervous | 0.50658644 |
| 101 | MP0010768_mortality/aging | 0.50238946 |
| 102 | MP0001943_abnormal_respiration | 0.49140080 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.48561199 |
| 104 | MP0003956_abnormal_body_size | 0.48491738 |
| 105 | MP0010770_preweaning_lethality | 0.48034940 |
| 106 | MP0002082_postnatal_lethality | 0.48034940 |
| 107 | MP0003121_genomic_imprinting | 0.47820696 |
| 108 | MP0004233_abnormal_muscle_weight | 0.46317394 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.46138605 |
| 110 | MP0010769_abnormal_survival | 0.45854093 |
| 111 | MP0002873_normal_phenotype | 0.45438033 |
| 112 | MP0003861_abnormal_nervous_system | 0.45120354 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.44841012 |
| 114 | MP0000026_abnormal_inner_ear | 0.44594583 |
| 115 | MP0002169_no_abnormal_phenotype | 0.43982846 |
| 116 | MP0002234_abnormal_pharynx_morphology | 0.43653064 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.43439662 |
| 118 | MP0003938_abnormal_ear_development | 0.42377473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 8.78300928 |
| 2 | Focal motor seizures (HP:0011153) | 7.75847324 |
| 3 | Focal seizures (HP:0007359) | 5.81730080 |
| 4 | Visual hallucinations (HP:0002367) | 5.17868561 |
| 5 | Action tremor (HP:0002345) | 4.29541867 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.22697048 |
| 7 | Ankle clonus (HP:0011448) | 3.96432571 |
| 8 | Febrile seizures (HP:0002373) | 3.94385682 |
| 9 | Atonic seizures (HP:0010819) | 3.88844189 |
| 10 | Poor eye contact (HP:0000817) | 3.86789361 |
| 11 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.79259878 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.76854579 |
| 13 | Absence seizures (HP:0002121) | 3.75530970 |
| 14 | Depression (HP:0000716) | 3.71360121 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.65566339 |
| 16 | Anxiety (HP:0000739) | 3.65537326 |
| 17 | Torticollis (HP:0000473) | 3.59629020 |
| 18 | Papilledema (HP:0001085) | 3.58182454 |
| 19 | Cerebral hypomyelination (HP:0006808) | 3.55186074 |
| 20 | Annular pancreas (HP:0001734) | 3.53021800 |
| 21 | Impaired social interactions (HP:0000735) | 3.47573070 |
| 22 | Abnormal social behavior (HP:0012433) | 3.47573070 |
| 23 | Dialeptic seizures (HP:0011146) | 3.45471141 |
| 24 | Broad-based gait (HP:0002136) | 3.44505157 |
| 25 | Dysdiadochokinesis (HP:0002075) | 3.40185475 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 3.34106638 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 3.32696071 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.30987218 |
| 29 | Focal dystonia (HP:0004373) | 3.27135292 |
| 30 | Resting tremor (HP:0002322) | 3.24409914 |
| 31 | Postural instability (HP:0002172) | 3.20946365 |
| 32 | Dysmetria (HP:0001310) | 3.20497167 |
| 33 | Craniofacial dystonia (HP:0012179) | 2.99775056 |
| 34 | Akinesia (HP:0002304) | 2.94347145 |
| 35 | Urinary urgency (HP:0000012) | 2.91900932 |
| 36 | Truncal ataxia (HP:0002078) | 2.90867770 |
| 37 | Abnormality of the lower motor neuron (HP:0002366) | 2.89629963 |
| 38 | Impaired smooth pursuit (HP:0007772) | 2.87831799 |
| 39 | Stereotypic behavior (HP:0000733) | 2.87663905 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.84032339 |
| 41 | Ankyloglossia (HP:0010296) | 2.81027564 |
| 42 | Ventricular fibrillation (HP:0001663) | 2.77901325 |
| 43 | Intention tremor (HP:0002080) | 2.77158682 |
| 44 | Amblyopia (HP:0000646) | 2.74330068 |
| 45 | Pointed chin (HP:0000307) | 2.73088408 |
| 46 | Spastic gait (HP:0002064) | 2.72123778 |
| 47 | Scanning speech (HP:0002168) | 2.71036998 |
| 48 | Megalencephaly (HP:0001355) | 2.67036333 |
| 49 | Mutism (HP:0002300) | 2.65356928 |
| 50 | Bradykinesia (HP:0002067) | 2.63305901 |
| 51 | Peripheral hypomyelination (HP:0007182) | 2.62445454 |
| 52 | Impaired vibratory sensation (HP:0002495) | 2.57427917 |
| 53 | Dysmetric saccades (HP:0000641) | 2.57179721 |
| 54 | Sleep apnea (HP:0010535) | 2.56415324 |
| 55 | Diminished motivation (HP:0000745) | 2.52034471 |
| 56 | Abnormality of the corticospinal tract (HP:0002492) | 2.51195512 |
| 57 | Bundle branch block (HP:0011710) | 2.46181791 |
| 58 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.45359414 |
| 59 | Hemiplegia (HP:0002301) | 2.44902592 |
| 60 | Spastic tetraparesis (HP:0001285) | 2.42887682 |
| 61 | Genetic anticipation (HP:0003743) | 2.42045658 |
| 62 | Hemiparesis (HP:0001269) | 2.41674096 |
| 63 | Hyperventilation (HP:0002883) | 2.34157391 |
| 64 | Neurofibrillary tangles (HP:0002185) | 2.32827122 |
| 65 | Abnormal EKG (HP:0003115) | 2.32139985 |
| 66 | Clonus (HP:0002169) | 2.30455202 |
| 67 | Choreoathetosis (HP:0001266) | 2.29075109 |
| 68 | Lower limb amyotrophy (HP:0007210) | 2.29066083 |
| 69 | Epileptiform EEG discharges (HP:0011182) | 2.27561253 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.24622557 |
| 71 | Prolonged QT interval (HP:0001657) | 2.23895716 |
| 72 | Insomnia (HP:0100785) | 2.23585302 |
| 73 | Progressive inability to walk (HP:0002505) | 2.21901161 |
| 74 | Cerebral inclusion bodies (HP:0100314) | 2.21863635 |
| 75 | Status epilepticus (HP:0002133) | 2.21112570 |
| 76 | Lower limb muscle weakness (HP:0007340) | 2.20350155 |
| 77 | Hypsarrhythmia (HP:0002521) | 2.18448127 |
| 78 | CNS hypomyelination (HP:0003429) | 2.15798335 |
| 79 | Obstructive sleep apnea (HP:0002870) | 2.13391955 |
| 80 | Polygenic inheritance (HP:0010982) | 2.11827650 |
| 81 | Increased circulating renin level (HP:0000848) | 2.11662546 |
| 82 | Limb dystonia (HP:0002451) | 2.11071535 |
| 83 | Excessive salivation (HP:0003781) | 2.09378627 |
| 84 | Drooling (HP:0002307) | 2.09378627 |
| 85 | Incomplete penetrance (HP:0003829) | 2.08905050 |
| 86 | Abnormality of binocular vision (HP:0011514) | 2.07606812 |
| 87 | Diplopia (HP:0000651) | 2.07606812 |
| 88 | Abnormality of the periventricular white matter (HP:0002518) | 2.06008672 |
| 89 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05422147 |
| 90 | Abnormality of oral frenula (HP:0000190) | 2.04354462 |
| 91 | Lower limb asymmetry (HP:0100559) | 2.03055769 |
| 92 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.96719425 |
| 93 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.96719425 |
| 94 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.95905850 |
| 95 | Polyphagia (HP:0002591) | 1.95060708 |
| 96 | Fetal akinesia sequence (HP:0001989) | 1.95018208 |
| 97 | Neuronal loss in central nervous system (HP:0002529) | 1.94759179 |
| 98 | Gait ataxia (HP:0002066) | 1.93059388 |
| 99 | Termporal pattern (HP:0011008) | 1.92585474 |
| 100 | Insidious onset (HP:0003587) | 1.92585474 |
| 101 | Generalized myoclonic seizures (HP:0002123) | 1.91727753 |
| 102 | Spinal canal stenosis (HP:0003416) | 1.91606403 |
| 103 | Abnormality of saccadic eye movements (HP:0000570) | 1.90763363 |
| 104 | Rigidity (HP:0002063) | 1.89810826 |
| 105 | Split foot (HP:0001839) | 1.89366926 |
| 106 | Heart block (HP:0012722) | 1.87129072 |
| 107 | Memory impairment (HP:0002354) | 1.85996594 |
| 108 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.85224956 |
| 109 | Aplasia of the phalanges of the hand (HP:0009802) | 1.85224956 |
| 110 | Aplasia involving bones of the extremities (HP:0009825) | 1.85224956 |
| 111 | Dementia (HP:0000726) | 1.84093501 |
| 112 | Absent speech (HP:0001344) | 1.82639617 |
| 113 | Pheochromocytoma (HP:0002666) | 1.81064925 |
| 114 | Tetraplegia (HP:0002445) | 1.79997292 |
| 115 | Bronchomalacia (HP:0002780) | 1.78503378 |
| 116 | Delusions (HP:0000746) | 1.75103203 |
| 117 | Upper limb amyotrophy (HP:0009129) | 1.73157595 |
| 118 | Distal upper limb amyotrophy (HP:0007149) | 1.73157595 |
| 119 | Slow saccadic eye movements (HP:0000514) | 1.73128490 |
| 120 | Atrioventricular block (HP:0001678) | 1.73058971 |
| 121 | Apathy (HP:0000741) | 1.72415093 |
| 122 | Rapidly progressive (HP:0003678) | 1.71717543 |
| 123 | Unsteady gait (HP:0002317) | 1.68576546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.30978708 |
| 2 | NTRK3 | 4.30669181 |
| 3 | MAP3K9 | 3.86640149 |
| 4 | PRKD3 | 3.15610955 |
| 5 | DAPK2 | 3.09853863 |
| 6 | KSR2 | 2.72949939 |
| 7 | MINK1 | 2.43359160 |
| 8 | CAMKK1 | 2.37445617 |
| 9 | RIPK4 | 2.31236736 |
| 10 | MAP3K4 | 2.24787431 |
| 11 | PAK6 | 2.23382836 |
| 12 | NTRK1 | 2.10506471 |
| 13 | MARK1 | 2.00678438 |
| 14 | NTRK2 | 1.88469456 |
| 15 | ARAF | 1.74550159 |
| 16 | MAP2K7 | 1.69625293 |
| 17 | DAPK1 | 1.68536506 |
| 18 | KSR1 | 1.68103339 |
| 19 | MAP3K13 | 1.67478313 |
| 20 | CDK5 | 1.65461311 |
| 21 | MAP3K2 | 1.63642262 |
| 22 | FES | 1.57617851 |
| 23 | TAOK1 | 1.48648435 |
| 24 | STK38 | 1.41235439 |
| 25 | PRPF4B | 1.38214095 |
| 26 | TYRO3 | 1.37668564 |
| 27 | MAP2K4 | 1.36169110 |
| 28 | SIK2 | 1.30501799 |
| 29 | TNIK | 1.27168776 |
| 30 | CAMKK2 | 1.26965514 |
| 31 | UHMK1 | 1.13641555 |
| 32 | RAF1 | 1.11004792 |
| 33 | GRK5 | 1.10228901 |
| 34 | PINK1 | 1.06516573 |
| 35 | PRKCG | 1.05706242 |
| 36 | PRKCH | 1.05632731 |
| 37 | MAP3K12 | 1.05228421 |
| 38 | CAMK1 | 0.99820591 |
| 39 | SGK223 | 0.95918785 |
| 40 | SGK494 | 0.95918785 |
| 41 | STK11 | 0.94537679 |
| 42 | CDK19 | 0.92259085 |
| 43 | BMPR2 | 0.91491195 |
| 44 | ALK | 0.90458998 |
| 45 | PLK2 | 0.88282327 |
| 46 | MAPK12 | 0.87923616 |
| 47 | MAP3K1 | 0.86984005 |
| 48 | CDK15 | 0.85977447 |
| 49 | CDK18 | 0.85685873 |
| 50 | RIPK1 | 0.84341104 |
| 51 | RET | 0.84168292 |
| 52 | CDK14 | 0.80947273 |
| 53 | CAMK2A | 0.79786013 |
| 54 | SGK3 | 0.79720928 |
| 55 | SGK2 | 0.79353557 |
| 56 | MAPK13 | 0.78753453 |
| 57 | PDK1 | 0.78663597 |
| 58 | PTK2B | 0.78408139 |
| 59 | MARK2 | 0.77546251 |
| 60 | PDPK1 | 0.77541431 |
| 61 | MAP3K11 | 0.75070712 |
| 62 | CDK11A | 0.75058359 |
| 63 | SGK1 | 0.74382129 |
| 64 | BRSK1 | 0.73445055 |
| 65 | CAMK2B | 0.70358957 |
| 66 | TNK2 | 0.69952068 |
| 67 | NEK1 | 0.63166486 |
| 68 | LIMK1 | 0.62924422 |
| 69 | NEK6 | 0.62920681 |
| 70 | PKN1 | 0.61823419 |
| 71 | LMTK2 | 0.61020912 |
| 72 | PNCK | 0.60037933 |
| 73 | PAK3 | 0.58864209 |
| 74 | DAPK3 | 0.55459803 |
| 75 | RPS6KA3 | 0.54060986 |
| 76 | MAP2K1 | 0.53964038 |
| 77 | CAMK4 | 0.53850112 |
| 78 | PHKG1 | 0.52797283 |
| 79 | PHKG2 | 0.52797283 |
| 80 | PRKD2 | 0.49746441 |
| 81 | PRKCZ | 0.49657129 |
| 82 | TESK1 | 0.48585046 |
| 83 | CDC42BPA | 0.48397784 |
| 84 | FYN | 0.48212904 |
| 85 | MAPK10 | 0.46986371 |
| 86 | DMPK | 0.46806297 |
| 87 | DYRK1A | 0.46390723 |
| 88 | FGFR2 | 0.45044206 |
| 89 | PRKG2 | 0.44278369 |
| 90 | LATS2 | 0.43985789 |
| 91 | MAP3K7 | 0.43784586 |
| 92 | SCYL2 | 0.41535521 |
| 93 | TRIB3 | 0.40077821 |
| 94 | WNK1 | 0.40016902 |
| 95 | ROCK2 | 0.39345760 |
| 96 | MAP2K6 | 0.38370333 |
| 97 | IRAK2 | 0.37496629 |
| 98 | CAMK2G | 0.37286708 |
| 99 | CAMK2D | 0.37067321 |
| 100 | OXSR1 | 0.36952659 |
| 101 | BRAF | 0.36889628 |
| 102 | CASK | 0.36648034 |
| 103 | PRKCE | 0.36175088 |
| 104 | PDGFRA | 0.34732143 |
| 105 | CSNK1G2 | 0.32904341 |
| 106 | PRKCB | 0.31960421 |
| 107 | MOS | 0.31879471 |
| 108 | ROCK1 | 0.29607855 |
| 109 | ERBB2 | 0.29265872 |
| 110 | MAPK8 | 0.29133712 |
| 111 | PRKCA | 0.27103219 |
| 112 | RPS6KA2 | 0.26825036 |
| 113 | CSNK1A1 | 0.26614372 |
| 114 | CAMK1G | 0.25620432 |
| 115 | CCNB1 | 0.25273997 |
| 116 | SRC | 0.22653867 |
| 117 | CAMK1D | 0.22410833 |
| 118 | GSK3B | 0.20332303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.30602247 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.06099376 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.03687701 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.76322965 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.71242662 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.67628971 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.65943830 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.62894194 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.56733531 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.45510972 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.27796518 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.15979724 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.14277326 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.13147888 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.12571441 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 2.12378286 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.01119726 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.97571644 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.94433799 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.77655034 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76621737 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.76153548 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.74338606 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.62345166 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.56083874 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.52212068 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.51781964 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.51563031 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.43309578 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40162484 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.34244024 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32662235 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29414792 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29273363 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.24743753 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18115819 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15308528 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08037194 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03804085 |
| 40 | Melanogenesis_Homo sapiens_hsa04916 | 1.03505841 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01354457 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98586281 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96460932 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94436433 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91688215 |
| 46 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89033363 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87187014 |
| 48 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84841099 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84818285 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 0.83650597 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83431451 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81529630 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81230494 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77224539 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76763667 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73995260 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72823660 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70913011 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70459756 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70176130 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.69909917 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68974799 |
| 63 | Alcoholism_Homo sapiens_hsa05034 | 0.68865413 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67874545 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67166009 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66911251 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66170898 |
| 68 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62525283 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62420485 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62412181 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58812101 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.55695558 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.55593913 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54768075 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54040594 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51268667 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.50148793 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49736908 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48846918 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48764126 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47078529 |
| 82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45934248 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45673214 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44895772 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44270841 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42595449 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42312808 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40589543 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39680806 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39540134 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.38360982 |
| 92 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38280027 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36796191 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35623261 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34020457 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.31409828 |
| 97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31060908 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.27516473 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26547740 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26538937 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26366086 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26005056 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25995000 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25050125 |
| 105 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24716976 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24191229 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24116313 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24098957 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21989767 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20258050 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.20183428 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.18781262 |

